Nurullah İlhan, Associate Professor of Medical Oncology/Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, Founder and Head of Medical Oncology Clinic, shared a post by Shaalan Beg, Senior Advisor for Clinical Research at the National Cancer Institute (NCI) and Chief Medical Officer at ConcertAI, adding:
“Pancreatic cancer is finally seeing real hope with KRAS inhibitors, neoantigen vaccines, and AI-powered early detection. These advances are game-changing.
Grateful to the entire team for breaking it down so clearly.”
Quoting Shaalan Beg‘s post:
“Pancreatic cancer will look very different in 5 years
- KRAS is no longer “undruggable”
- Neoantigen vaccines may stop recurrence
- AI can identify ‘occult’ tumors from routine scans
We tackle these stories in our new episode.”